Ido Agmon
Independent DirectorMr. Ido Agmon, MBA, has been a Manager of Aviv New-Tech (formerly Aviv Bio-Invest) since 2014. Mr. Agmon is a co-founder of Aviv New-Tech and where he is responsible for analysis and evaluation of investments in Israeli and global biomed companies. Since 2012, Mr. Agmon also has been an Independent Consultant, providing start-ups and technology-based ventures with advice in strategic planning and fund-raising. From 2009 to 2011, Mr. Agmon served as the Co-Chief Executive Officer of Meytav Technological Incubator, an Israeli-based accelerator for biotech, pharma & medtech ventures with over 20 portfolio companies. From 2007 to 2009, he worked as the Director of Business Development of ATI incubator, a technology incubator specializing in biomed and cleantech projects, responsible for deal-flow and project evaluation. Prior to this, he served as the Vice President of Business Development at ATI Technology Incubator and was responsible for the evaluation and promotion of new investments in the incubator and other business development activities. Before joining the Biomedix group, Mr. Agmon served as a Director of Professional Services at FreeMind Consulting Group specialized in academic and commercial research and development plans, grant writing consultation and fund-raising activities for high-tech companies. He serves as Chairman of EZ Orthopedics Limited. Mr. Agmon has been an Independent Director of Purple Biotech Ltd. (formerly known as Kitov Pharma Ltd) (Formerly known as Kitov Pharmaceuticals Holdings Ltd.) since June 26, 2016. He serves as a Director of CytoD Ltd. He serves as a Director of Pep2Life. He holds an M.B.A. in Marketing and Finance from the Hebrew University in Jerusalem and a B.Sc. in Business Administration, Life Sciences and Management from Tel Aviv University, Israel.
Positions
- Company NamePurple Biotech LtdStock CodePPBTPositionIndependent DirectorColleagues
- IIIsaac IsraelInterim Chief Executive Officer & Director
- EKEric K. RowinskyIndependent Chairman of the Board
- SLShai LankryChief Financial Officer
- GEGil EfronHead of Corporate Development & Executive Director
- MSMichael SchicklerHead of Clinical & Regulatory Affairs
- SNSuzana Nahum-ZilberbergIndependent Director
